J Clin Periodontol. 2022 Oct 19. doi: 10.1111/jcpe.13735. Online ahead of print.
ABSTRACT
AIM: To assess any differences (1) in the prevalence of periodontitis and necrotizing periodontal diseases, specifically necrotizing gingivitis (NG) and necrotizing periodontitis (NP) between HIV patients receiving antiretroviral therapy (HAART) and those not receiving the therapy and (2) in the severity of periodontitis based on probing depths (PD) and clinical attachment loss (CAL) between the two groups.
MATERIALS AND METHODS: Systematic electronic search on 5 databases (PubMed, Google Scholar, Scopus, Web of Science and Scielo) was conducted to identify cross-sectional and longitudinal studies reporting on prevalence of NG, NP, and periodontitis among HIV patients who either receive or do not receive HAART treatment. The differences on clinical parameters of probing depths (PD) and clinical attachment loss (CAL) among these patients was assessed.
RESULTS: 18 articles were considered. The meta-analysis for NG showed that the overall assessment for the relative frequency ratio in the two groups was 0.45 (n=7;95%CI: [0.21-0.97]; p<0.042). Regarding NP the overall assessment for the relative frequency ratio in both groups was 0.60 (n=5;95%CI: [0.22-1.64]; p=0.321). In regards to periodontitis the overall assessment for the relative frequency ratio in the two groups was 1.17 (n=9;95%CI: [0.90-1.52]; p=0.248). No significant differences in PD and CAL were found between the two groups 0.00 (n=3; 95%CI: [-0.52-0.53]; p=0.985) and 0.32 (n=3; 95%CI:[ -0.19-0.82]; p=0.22) respectively.
CONCLUSIONS: The prevalence of NG appeared to be significantly reduced in patients receiving antiretroviral therapy. No statistical significant difference was found in the prevalence of NP or periodontitis between the two groups. This article is protected by copyright. All rights reserved.
PMID:36261851 | DOI:10.1111/jcpe.13735
